g.tec: Leading the Charge in BCI Technology
What does your business focus on, and how is it positioned in the market?
Our business specializes in developing state-of-the-art brain-computer interface (BCI) and neurotechnology solutions that empower researchers, clinicians, and innovators to unlock the brain’s potential. Our products cater to a wide range of applications, including neuroscience research, clinical rehabilitation, education, and interactive technologies.
g.tec is a global leader in the BCI field, with over two decades of expertise. We distinguish ourselves by offering a comprehensive product portfolio that includes high-quality EEG systems, real-time signal processing software, and groundbreaking applications such as recoveriX for stroke rehabilitation and mindBEAGLE for assessing consciousness.
Our solutions stand out for their ease of use, superior signal quality, and robust customization options through APIs, attracting a diverse audience ranging from top researchers and universities to companies and developers creating next-generation technologies.
Through continuous innovation and strong collaborations with academic and industry leaders, g.tec remains at the forefront of the rapidly evolving field of neurotechnology and BCI.
Expanding Horizons: Plans for Growth
What are your plans for growth or expansion in the near future?
Our growth plans revolve around advancing our technologies and entering new clinical and research domains. With recoveriX, our stroke rehabilitation system, we’re achieving remarkable results and expanding its applications. New clinical studies reveal its effectiveness not only for stroke patients but also for individuals with multiple sclerosis (MS) and Parkinson’s disease. Additionally, case studies have shown significant improvements in patients with spinal cord injuries, highlighting recoveriX’s versatility.
In the area of brain mapping, we’re introducing a revolutionary system capable of measurements with 1,024 EEG electrodes, offering unprecedented spatial resolution. This breakthrough will enable researchers to revisit and refine previous studies, unveiling new insights into brain activity and function.
With cortiQ, we are integrating electrical stimulation to enhance brain mapping for neurosurgeons. This innovation helps identify eloquent cortical areas with speed and precision, even in pediatric patients, significantly improving surgical outcomes.
By continually expanding our technology’s capabilities and applications, we aim to push the boundaries of neurotechnology and improve lives across clinical, research, and medical fields.